Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen.

"Declarations Ethics approval and consent to participatePatients provided written informed consent at trial enrollment. The trial was conducted in accordance with the Declaration of Helsinki and was approved by the Lead Ethics Committee and registered at clinicaltrialsregister.eu (EudraCT Number: 2009-016142-44) and clinicaltrials.gov (ClinicalTrials.gov Identifier: NCT01180322). Consent for publicationNot applicable. Competing interests.The authors declare no competing interests. Competing interests. The authors declare no competing interests."

"Funding Open Access funding enabled and organized by Projekt DEAL. This study was supported in part by the Deutsche Krebshilfe (DKH 110530)."

"Declarations: Ethics approval and consent to participatePatients provided written informed consent at trial enrollment. The trial was conducted in accordance with the Declaration of Helsinki and was approved by the Lead Ethics Committee and registered at clinicaltrialsregister.eu (EudraCT Number: 2009-016142-44) and clinicaltrials.gov (ClinicalTrials.gov Identifier: NCT01180322).: Consent for publicationNot applicable.: Competing interests.The authors declare no competing interests. Ethics approval and consent to participate: Patients provided written informed consent at trial enrollment. The trial was conducted in accordance with the Declaration of Helsinki and was approved by the Lead Ethics Committee and registered at clinicaltrialsregister.eu (EudraCT Number: 2009-016142-44) and clinicaltrials.gov (ClinicalTrials.gov Identifier: NCT01180322)."